Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
FGF1 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Supplier: Thermo Scientific PA550489
Description
The antibody detects endogenous levels of total FGF1 protein.
FGF1 Polyclonal antibody specifically detects FGF1 in Human, Mouse, Rat samples. It is validated for Immunohistochemistry (Paraffin).Specifications
FGF1 | |
Polyclonal | |
Unconjugated | |
FGF1 | |
acidic eye-derived fibroblast growth factor; acidic eye-derived growth factor II; Acidic fibroblast growth factor; aFGF; beta-endothelial cell growth factor; Dffrx; ECGF; ECGFA; ECGFB; ECGF-beta; EDGF; EDGF II; Endothelial cell growth factor; Endothelial cell growth factor alpha; Endothelial cell growth factor beta; endothelial cell growth factor beta and alpha chains; endothelial cell growth factor, alpha; endothelial cell growth factor, beta; endothelial growth factor; Fam; FGF; FGF1; Fgf-1; FGF1 protein; Fgfa; FGF-alpha; Fibroblast growth factor; Fibroblast growth factor 1; fibroblast growth factor 1 (acidic); Fibroblast growth factor 1 (heparin binding); fibroblast growth factor, acidic; GLIO703; HBGF1; HBGF-1; heparin-binding growth factor; Heparin-binding growth factor 1; H-FGF-a; M-FGF-a; Prostatropin; unnamed protein product | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
14164, 2246, 25317 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin) | |
1.2 mg/mL | |
PBS with 40% glycerol and 0.05% sodium azide; pH 7.4 | |
P05230, P61148, P61149 | |
FGF1 | |
Synthetic peptide corresponding to a region derived from internal residues of human Fibroblast growth factor 1 | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction